(1)
José Luis Ordoñez-Librado, Ana Luisa Gutierrez-Valdez, Jesus Espinosa-Villanueva, Enrique Montiel-Flores, Patricia Aley-Medina, Javier Sánchez-Betancourt, Claudia Dorado-Martínez, Leonardo Reynoso-Erazo, Rocío Tron-Alvarez & Vianey Rodríguez-Lara. L-DOPA/Capsazepine/or/L-DOPA/Rimonabant/Co-Administration/in/an/Experimental/Parkinson/Disease/Model:/Behavioral/and/Cellular/Consequences. IDMMR-V5 2022, 35-60.